Article
In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies…
medRxiv · 2023 · Jean-François Rivest
Key facts
| Title | In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1 |
|---|---|
| First author | Jean-François Rivest |
| Journal | medRxiv |
| Published | Sep 29, 2023 |
| DOI | 10.1101/2023.09.29.559947 |
| Devices mentioned | 203500 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1